Micro- and Nanotechnology in Vaccine Development

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Science & Nature, Technology, Engineering, Chemical & Biochemical
Cover of the book Micro- and Nanotechnology in Vaccine Development by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780323400299
Publisher: Elsevier Science Publication: September 20, 2016
Imprint: Elsevier Language: English
Author:
ISBN: 9780323400299
Publisher: Elsevier Science
Publication: September 20, 2016
Imprint: Elsevier
Language: English

This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress.

MNT allows the creation of particles that exploit the inherent ability of the human immune system to recognize small particles such as viruses and toxins. In combination with minimal protective epitope design, this permits the creation of immunogenic particles that stimulate a response against the targeted pathogen. The finely tuned response of the human immune system to small particles makes it unsurprising that many of the lead adjuvants and vaccine delivery systems currently under investigation are based on nanoparticles.

  • Provides a comprehensive and unparalleled overview of the role of micro- and nanotechnology in vaccine development
  • Allows researchers to quickly familiarize themselves with the broad spectrum of vaccines and how micro- and nanotechnologies are applied to their development
  • Includes a combination of overview chapters setting out general principles, and focused content dealing with specific vaccines, making it useful to readers from a variety of disciplines
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress.

MNT allows the creation of particles that exploit the inherent ability of the human immune system to recognize small particles such as viruses and toxins. In combination with minimal protective epitope design, this permits the creation of immunogenic particles that stimulate a response against the targeted pathogen. The finely tuned response of the human immune system to small particles makes it unsurprising that many of the lead adjuvants and vaccine delivery systems currently under investigation are based on nanoparticles.

More books from Elsevier Science

Cover of the book Biotechnology Entrepreneurship by
Cover of the book Handbook of Plasticizers by
Cover of the book Fundamentals of Biologicals Regulation by
Cover of the book Continuous Architecture by
Cover of the book Advances in Heterocyclic Chemistry by
Cover of the book Handbook of Silicon Wafer Cleaning Technology by
Cover of the book Primary Immunodeficiency Disorders by
Cover of the book Advances in the Study of Behavior by
Cover of the book Posttraumatic Stress Disorder by
Cover of the book Disappearing Cryptography by
Cover of the book International Review of Cell and Molecular Biology by
Cover of the book Renewable Energy Integration by
Cover of the book Efficient Livestock Handling by
Cover of the book Video Coding for Mobile Communications by
Cover of the book Micromechanics of Composites by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy